SPHERE FLUIDICS
Sphere Fluidics Limited is a new Life Sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services in this area.
SPHERE FLUIDICS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2010-02-24
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.spherefluidics.com
Total Employee:
11+
Status:
Active
Contact:
441223804210
Email Addresses:
[email protected]
Total Funding:
61.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Apache
Similar Organizations
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sofinnova Partners
Sofinnova Partners investment in Venture Round - Sphere Fluidics
Redmile Group
Redmile Group investment in Venture Round - Sphere Fluidics
Oxford Investment Consultants LLP
Oxford Investment Consultants LLP investment in Venture Round - Sphere Fluidics
Greenwood Way Capital
Greenwood Way Capital investment in Venture Round - Sphere Fluidics
24 Haymarket
24 Haymarket investment in Venture Round - Sphere Fluidics
Eurostars
Eurostars investment in Grant - Sphere Fluidics
Innovate UK
Innovate UK investment in Grant - Sphere Fluidics
University of Edinburgh
University of Edinburgh investment in Grant - Sphere Fluidics
Twist Bioscience
Twist Bioscience investment in Grant - Sphere Fluidics
Horizon Discovery
Horizon Discovery investment in Grant - Sphere Fluidics
Newest Events participated
Key Employee Changes
Date | New article |
---|---|
2022-05-10 | Sphere Fluidics Strengthens Commercial Team With Three New Senior Hires |
Official Site Inspections
http://www.spherefluidics.com Semrush global rank: 4.57 M Semrush visits lastest month: 2.26 K
- Host name: 77.68.80.18
- IP address: 77.68.80.18
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Sphere Fluidics" on Search Engine
Sphere Fluidics - Wikipedia
Sphere Fluidics is a Cambridge(UK)-based Life Sciences R&D company that specializes in biopharmaceutical discovery and development, cell therapy engineering, bioproduction and synthetic biology, analysis and isolation. The company is reported to own 25 patented products that include instruments, biochips, and specialist chemicals.See details»
Sphere Fluidics - Crunchbase Company Profile & Funding
Company Type For Profit. Contact Email [email protected]. Phone Number 441223804210. Sphere Fluidics Limited is a new Life Sciences company which has โฆSee details»
Sphere Fluidics Limited | LinkedIn
Great Abington, Cambridge. Type. Privately Held. Founded. 2010. Specialties. biopharmaceutical, lab-on-a-chip, cells, antibodies, enzymes, cancer, biologics, โฆSee details»
Sphere
Sphere Fluidics has also been successful in joining a leading syndicate includ-ing a major biopharma company, a contract manu-facturing organization, a genome-editing โฆSee details»
Accelerating biologic drug discovery with picodroplet โฆ
By improving single-cell analysis, Sphere Fluidicsโ microfluidics technology is providing new options for antibody discovery and cell-line development. Picodroplet technology โฆSee details»
Sphere Fluidics Closes a $40 Million Funding Round Led โฆ
Oct 28, 2021 CAMBRIDGE, England-- ( BUSINESS WIRE )--Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by โฆSee details»
Sphere Fluidics Updates Brand Identity to Align With โฆ
May 23, 2023 CAMBRIDGE, England-- ( BUSINESS WIRE )--Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented โฆSee details»
Sphere Fluidics closes a $40 million funding round led by โฆ
Oct 28, 2021 Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, โฆSee details»
Accelerating biologic drug discovery with picodroplet technology
Sphere Fluidics Ltd. Produced by. Picodroplet technology can be used to find rare and valuable variants within heterogeneous cell samples, which makes it well suited for โฆSee details»
Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer
Cambridge, UK, 30 April, 2024: Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the โฆSee details»
Sphere Fluidics Appoints Dale Levitzke as Chief Executive Officer
CAMBRIDGE, England, April 30, 2024 -- ( BUSINESS WIRE )--Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, โฆSee details»
Sphere Fluidics Plans New Applications for Single-Cell Isolation, โฆ
Dec 14, 2021 NEW YORK โ Sphere Fluidics is planning to use a recent fundraising round to build out new applications for its Cyto-Mine single-cell isolation and assay platform, โฆSee details»
Sphere Fluidics Begins Work With Partners on 3DSecret โฆ
Apr 24, 2023 CAMBRIDGE, England-- ( BUSINESS WIRE )--Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet โฆSee details»
Sphere Fluidics closes a $40 million funding round led by โฆ
Oct 28, 2021 Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, โฆSee details»
Sphere Fluidics' Expansion and Vision - News-Medical.net
Oct 25, 2023 Congratulations on the completion of Sphere Fluidics' new state-of-the-art facilities. Can you tell us about the significance of this expansion and how it aligns with โฆSee details»
Sphere Fluidics appoints Dr. Graeme Daniels as Vice President โฆ
Dec 14, 2023 Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing - Sphere Fluidics. Products. Platforms. Cyto-Mine®. Antibody Discovery โฆSee details»
Sphere Fluidics strengthens commercial team with three new โฆ
May 10, 2022 Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has โฆSee details»
Sphere Fluidics announces enhanced Cyto-Mine capability and โฆ
May 18, 2021 Street Address. City. State/Region. Zip Code. Country* Keywords. Sphere Fluidics, a company developing single cell analysis systems underpinned by its โฆSee details»
Sphere Fluidics begins work with partners on 3DSecret program โฆ
Apr 24, 2023 Sphere Fluidics, a company developing single-cell analysis systems underpinned by its patented picodroplet technology, today announced its involvement in โฆSee details»
Medtronic Afferaโข Mapping and Ablation System with Sphere
2 days ago The Sphere-9 Catheter demonstrated a positive safety profile with an excellent primary safety endpoint rate of 1.4% (1.0% for the control arm). Importantly, no safety โฆSee details»